Mesoblast (MESO) - 2026 Q2 - Earnings Call Transcript
Mesoblast (NasdaqGS:MESO) H1 2026 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsJames O'Brien - CFOMarcelo Santoro - Chief Commercial OfficerPaul Hughes - Head of Corporate Finance and Investor RelationsSilviu Itescu - CFO and Managing DirectorConference Call ParticipantsEdward Tenthoff - Managing Director and Senior Research AnalystMadeleine Williams - Equity Research AnalystMichael Okunewitch - Biotechnology Senior Research AnalystOlivia Brayer - Director and Senior Biotech AnalystOperat ...